Cao, Y., . F. . Shi, Y. . Li, X. . Wei, . H. . Yi, and S. . Han. “Cost-Effectiveness Analysis of the Combination of Low-Dose Nivolumab With Triple Metronomic Chemotherapy for Advanced Head and Neck Squamous Cell Carcinoma in China”. Health Decision, vol. 2, no. S1, July 2024, doi:10.54844/hd.2024.0008.